Literature DB >> 25940452

Bone density and microarchitecture in endogenous hypercortisolism.

Camila V dos Santos1, Leonardo Vieira Neto1,2, Miguel Madeira1,3, Maria Caroline Alves Coelho1, Laura Maria Carvalho de Mendonça4, Francisco de Paula Paranhos-Neto1, Inayá Corrêa Barbosa Lima5, Mônica R Gadelha1, Maria Lucia Fleiuss Farias1.   

Abstract

OBJECTIVE: Osteoporosis is a serious and underestimated complication of endogenous hypercortisolism that results in an increased risk of fractures, even in patients with normal or slightly decreased bone mineral density (BMD). Alterations in bone microarchitecture, a very important component of bone quality, may explain bone fragility. The aim of this study was to investigate bone density and microarchitecture in a cohort of patients with endogenous Cushing's syndrome (CS).
DESIGN: Cross-sectional study. PATIENTS: Thirty patients with endogenous active CS and fifty-one age-, sex- and body mass index-matched controls were included. MEASUREMENTS: Participants were studied for areal BMD (dual-energy X-ray absorptiometry) of the lumbar spine (LS), femoral neck (FN), total femur (TF) and radius (33%), and for volumetric bone density (vBMD) and structure using high-resolution peripheral quantitative computed tomography (HR-pQCT) of the distal radius and distal tibia.
RESULTS: Patients with active CS exhibited lower areal BMD and Z-score values in the LS, FN and TF (P < 0·003 for all comparisons). At HR-pQCT, the patients with CS also had lower cortical area (P = 0·009 at the radius and P = 0·002 at the tibia), lower cortical thickness (P = 0·02 at the radius and P = 0·002 at the tibia), lower cortical density (P = 0·008 at the tibia) and lower total vBMD (P = 0·002 at the tibia). After the exclusion of hypogonadal individuals, the patients with CS maintained the same microarchitectural and densitometric alterations described above.
CONCLUSIONS: Endogenous hypercortisolism has deleterious effects on bone, especially on cortical bone microstructure. These effects seem to be a more important determinant of bone impairment than gonadal status.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25940452     DOI: 10.1111/cen.12812

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  8 in total

Review 1.  Secondary Osteoporosis and Metabolic Bone Diseases.

Authors:  Mahmoud M Sobh; Mohamed Abdalbary; Sherouk Elnagar; Eman Nagy; Nehal Elshabrawy; Mostafa Abdelsalam; Kamyar Asadipooya; Amr El-Husseini
Journal:  J Clin Med       Date:  2022-04-24       Impact factor: 4.964

2.  High bone marrow fat in patients with Cushing's syndrome and vertebral fractures.

Authors:  Francesco Ferraù; Salvatore Giovinazzo; Erika Messina; Agostino Tessitore; Sergio Vinci; Gherardo Mazziotti; Andrea Lania; Francesca Granata; Salvatore Cannavò
Journal:  Endocrine       Date:  2019-08-02       Impact factor: 3.633

3.  Lower extremity insufficiency fractures: an underappreciated manifestation of endogenous Cushing's syndrome.

Authors:  S Poonuru; J W Findling; J L Shaker
Journal:  Osteoporos Int       Date:  2016-08-15       Impact factor: 4.507

4.  Decreased Trabecular Bone Score in Patients With Active Endogenous Cushing's Syndrome.

Authors:  Barbara Stachowska; Jowita Halupczok-Żyła; Justyna Kuliczkowska-Płaksej; Joanna Syrycka; Marek Bolanowski
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-21       Impact factor: 5.555

Review 5.  Peripheral quantitative computed tomography (pQCT) for the assessment of bone strength in most of bone affecting conditions in developmental age: a review.

Authors:  Stefano Stagi; Loredana Cavalli; Tiziana Cavalli; Maurizio de Martino; Maria Luisa Brandi
Journal:  Ital J Pediatr       Date:  2016-09-26       Impact factor: 2.638

6.  Effect of hypercortisolism on bone mineral density and bone metabolism: A potential protective effect of adrenocorticotropic hormone in patients with Cushing's disease.

Authors:  Weihong Guo; Fengao Li; Chonggui Zhu; Baoping Wang; Kunling Wang; Chenlin Dai; Hongwei Jia; Hongyan Wei; Qing He; Jin Cui; Menghua Yuan; Shaofang Tang; Wei Liu; Tiehong Zhu; Zhihong Gao; Fangqiu Zheng; Zhongshu Ma; Huiqi Qu; Mei Zhu
Journal:  J Int Med Res       Date:  2017-08-29       Impact factor: 1.671

7.  Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome.

Authors:  Joshua Kannankeril; Ty Carroll; James W Findling; Bradley Javorsky; Ian L Gunsolus; Jonathan Phillips; Hershel Raff
Journal:  J Endocr Soc       Date:  2020-07-24

8.  The CRH-Transgenic Cushingoid Mouse Is a Model of Glucocorticoid-Induced Osteoporosis.

Authors:  Jasmine Williams-Dautovich; Keertika Yogendirarajah; Ariana Dela Cruz; Rucha Patel; Ricky Tsai; Stuart A Morgan; Jane Mitchell; Marc D Grynpas; Carolyn L Cummins
Journal:  JBMR Plus       Date:  2017-06-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.